Maa: Kanada
Kieli: englanti
Lähde: Health Canada
CHLORHEXIDINE GLUCONATE
GERMIPHENE CORPORATION
A01AB03
CHLORHEXIDINE
0.12%
MOUTHWASH
CHLORHEXIDINE GLUCONATE 0.12%
BUCCAL
500ML/4L
Prescription
MISCELLANEOUS ANTI-INFECTIVES
Active ingredient group (AIG) number: 0107629007; AHFS:
APPROVED
2007-02-21
_ _ _Appendix E- Product Monograph Template Standard _ _Page 1 of 16_ PRODUCT MONOGRAPH Pr ORO CLEAR ® Chlorhexidine Gluconate Oral Rinse, 0.12% w/v House Standard Antigingivitis Oral Rinse Germiphene Corporation 1379 Colborne Street East, Brantford, ON N3T 5M1> www.germiphene.com Date of Preparation: February 15, 2007 Date of Revision: November 2, 2015 Submission Control No: 161506 © 2015 Germiphene Corporation All trademarks used under license. _ _ _Appendix E- Product Monograph Template Standard _ _Page 2 of 16_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ...................................................................... 3 SUMMARY PRODUCT INFORMATION .................................................................................... 3 INDICATIONS AND CLINICAL USE .......................................................................................... 3 CONTRAINDICATIONS ............................................................................................................... 3 WARNINGS AND PRECAUTIONS .............................................................................................. 3 ADVERSE REACTIONS ................................................................................................................ 4 DRUG INTERACTIONS ................................................................................................................ 5 DOSAGE AND ADMINISTRATION ............................................................................................ 6 OVERDOSAGE .............................................................................................................................. 7 ACTION AND CLINICAL PHARMACOLOGY .......................................................................... 7 STORAGE AND STABILITY ........................................................................................................ 7 SPECIAL HANDLING INSTRUCTIONS ..................................................................................... 7 DOSAGE FORMS, COMPO Lue koko asiakirja